The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks65WK.L Regulatory News (65WK)

  • There is currently no data for 65WK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

7 Apr 2022 15:22

RNS Number : 6962H
Santander UK Plc
07 April 2022
 

SANTANDER UK PLC€35 BILLION GLOBAL COVERED BOND PROGRAMMEPublication of Final Terms - Series 78

The following final terms (the Final Terms) are available for viewing:

Issue of Series 78 €1,750,000,000 Fixed Rate Covered Bonds due 12 March 2027 (ISIN XS2466426215) under the €35 billion Global Covered Bond Programme of Santander UK plc (the Programme).

To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6962H_1-2022-4-7.pdf

A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Final Terms can also be viewed at: https://www.santander.co.uk/uk/about-santander-uk/debt-investors/santander-uk-covered-bonds.

Please see Annex 1 to this notice for additional information in relation to the Series 78 Covered Bonds.

For further information, please contact:

Medium Term FundingSantander UK plc2 Triton SquareRegent's PlaceLondon NW1 3AN

Email: mtf@santander.co.uk

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms and the base prospectus published in respect of the Programme on 4 March 2022 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus you must ascertain from the Final Terms and the Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.

 

 

ANNEX 1

ADDITIONAL INFORMATION IN RELATION TO SERIES 78 €1,750,000,000 FIXED RATE COVERED BONDS DUE 12 MARCH 2027

OPERATIONAL INFORMATION DOCUMENT

This Operational Information Document related to the Final Terms dated 6 April 2022 (the Final Terms) in respect of the issue of Series 78 €1,750,000,000 Fixed Rate Covered Bonds due 12 March 2027 (ISIN XS2466426215).

This Operational Information Document has not been reviewed or approved by any competent authority for the purposes of the UK Prospectus Regulation or otherwise and does not form part of the Final Terms for the purposes of the UK Prospectus Regulation. However, for all other purposes this Operational Information Document must be read in conjunction with the Final Terms. Words and expressions which have a defined meaning in the Final Terms or Base Prospectus dated 4 March 2022 and have the same meanings in this Operational Information Document.

DISTRIBUTION

(a) If syndicated, names of Joint Lead Managers: Banco Santander, S.A.;

ABN AMRO Bank N.V.;

BNP Paribas;

Deutsche Bank AG, London Branch; and

Landesbank Baden-Württemberg

(each a "Joint Lead Manager" and together, the "Joint Lead Managers")

(b) Date of Subscription Agreement: 6 April 2022

(c) If not syndicated, name of relevant Dealer: Not applicable

(d) U.S. Selling Restrictions: Regulation S

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBKOBBQBKDDQK
12
Date   Source Headline
7th Apr 20223:22 pmRNSPublication of Final Terms
1st Apr 20226:15 pmRNSResult of AGM
22nd Mar 20224:43 pmRNSPublication of Final Terms
7th Mar 202210:08 amRNSCovered Bond Programme - Publication of Prospectus
2nd Mar 20227:15 amRNSAnnual Financial Report
2nd Mar 20227:15 amRNSAnnual Financial Report
2nd Feb 20221:58 pmRNSPublication of Suppl.Prospcts
2nd Feb 20221:46 pmRNSSupplemental Prospectus
2nd Feb 20227:15 amRNSQuarterly Management Statement - Q4 2021
21st Jan 20221:26 pmRNSArticle 17 notification - Issue 1197
21st Jan 20221:24 pmRNSArticle 17 notification - Issue 1196
21st Jan 20221:24 pmRNS1195 LSE Cancellation Announcement
5th Jan 20222:23 pmRNSNotice of Early Redemption
24th Dec 20218:47 amRNSIntention To Exercise Regulatory Call
23rd Dec 20211:55 pmRNS1193 Cancellation Announcement
10th Dec 20211:28 pmRNSARTICLE 17 NOTIFICATION - Issue 1194
6th Dec 20219:05 amRNSSantander UK - Board Changes
29th Nov 20217:00 amRNSDirectorate Change
1st Nov 20217:00 amRNSSupplemental Prospectus
1st Nov 20217:00 amRNSSupplemental Prospectus
29th Oct 20215:23 pmRNSAMENDMENTS TO COVERED BOND SWAPS
27th Oct 20217:15 amRNSQuarterly Management Statement - Q3 2021
18th Oct 20211:35 pmRNS1191 Cancellation Announcement
18th Oct 202111:11 amRNSIssue 1192 Article 17 notification
7th Oct 20211:12 pmRNSIssue 623 amended and restated
1st Oct 202111:33 amRNSDirectorate Change
21st Sep 20213:08 pmRNSTender Offer - Results
20th Sep 202112:28 pmRNSTender Offer Results
17th Sep 20215:08 pmRNSSantander UK plc Tender Offer Pricing
13th Sep 20211:48 pmRNSSantander UK plc Tender Offer
13th Sep 20219:25 amRNSSantander UK plc Tender Offer
23rd Aug 20211:24 pmRNSArticle 17 Notification - 1189 (ISIN XS2352402387)
16th Aug 20211:53 pmRNSSantander UK plc - Board Change
13th Aug 20213:22 pmRNSSupplementary Prospectus EMTN Programme
13th Aug 20217:15 amRNSHalf-year Report - 30 June 2021
28th Jul 20213:36 pmRNSSupplemental Prospectus
28th Jul 20217:15 amRNSQ2 2021 Results and Board Change
16th Jul 20211:42 pmRNSNOTICE OF EARLY REDEMPTION - ISIN: XS2359958241
12th Jul 20211:30 pmRNSIssue 1187 XS2326323305 Article 17 notification
2nd Jul 20219:04 amRNSPart VII Banking Business Transfer Scheme
21st Jun 20214:30 pmRNSPricing Announcement
21st Jun 20213:55 pmRNSFinal Results of Tender Offer
21st Jun 202112:52 pmRNSEarly Results Announcement
21st Jun 202110:17 amRNSIndicative Results Announcement (non-US Offer)
14th Jun 20218:32 amRNSTender Offer
7th Jun 20212:57 pmRNSCash Tender Offers for two series of Notes
1st Jun 20217:00 amRNSArticle 17 Notification - 1185 (ISIN XS2294359570)
12th May 20214:17 pmRNSPublication of Prospectus
12th May 20214:13 pmRNSPublication of Prospectus
30th Apr 20216:20 pmRNSPublication of Supplementary Prospectus
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.